NCT06693284 2026-05-29A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]University of MinnesotaPhase EARLY_PHASE1 Recruiting8 enrolled